FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117700031> ?p ?o ?g. }

• W2117700031 endingPage "364" @default.
• W2117700031 startingPage "359" @default.
• W2117700031 abstract "Summary We have demonstrated spontaneous development of autoimmune cholangitis, similar to human primary biliary cirrhosis, in mice expressing a dominant negative form of the transforming growth factor-β receptor (dnTGF-βRII) restricted to T cells. The autoimmune cholangitis appears to be mediated by autoreactive CD8+ T lymphocytes that home to the portal tracts and biliary system. Because the liver pathology is primarily secondary to CD8+ T cells, we have determined herein whether administration of β-glucosylceramide (GC), a naturally occurring plant glycosphingolipid, alters the natural history of disease in this model. We chose GC because previous work has demonstrated its ability to alter CD8+ T cell responses and to down-regulate tissue inflammation. Accordingly, dnTGF-βRII mice were treated with either GC or control for a period of 18 weeks beginning at 6 weeks of age. Importantly, in mice that received GC, there was a significant decrease in the frequency and absolute number of autoreactive liver-infiltrating CD8+ T cells, accompanied by a significant decrease in activated CD44high CD8+ T cell populations. Further, there was a significant reduction in portal inflammation in GC-treated mice. Interestingly, there were no changes in anti-mitochondrial antibodies, CD4+ T cells, CD19+ B cells or natural killer (NK) T cell populations, indicating further that the beneficial effects of GC on liver inflammation were targeted specifically to liver-infiltrating CD8+ T cells. These data suggest that further work on GC in models of CD8+ T-mediated inflammation are needed and point to a new therapeutic venue for potentially treating and/or modulating autoimmune disease." @default.
• W2117700031 created "2016-06-24" @default.
• W2117700031 creator A5019715351 @default.
• W2117700031 creator A5022147284 @default.
• W2117700031 creator A5029678899 @default.
• W2117700031 creator A5056019322 @default.
• W2117700031 creator A5056439899 @default.
• W2117700031 creator A5064226135 @default.
• W2117700031 creator A5080746000 @default.
• W2117700031 date "2009-05-06" @default.
• W2117700031 modified "2023-09-23" @default.
• W2117700031 title "β-Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis" @default.
• W2117700031 cites W1518854271 @default.
• W2117700031 cites W1635401440 @default.
• W2117700031 cites W1650215555 @default.
• W2117700031 cites W1843209045 @default.
• W2117700031 cites W1966337867 @default.
• W2117700031 cites W1974348376 @default.
• W2117700031 cites W1974641004 @default.
• W2117700031 cites W1975364982 @default.
• W2117700031 cites W1977492688 @default.
• W2117700031 cites W1977644244 @default.
• W2117700031 cites W1979109977 @default.
• W2117700031 cites W1983571376 @default.
• W2117700031 cites W1984162039 @default.
• W2117700031 cites W1991467455 @default.
• W2117700031 cites W2011647252 @default.
• W2117700031 cites W2032387601 @default.
• W2117700031 cites W2042872080 @default.
• W2117700031 cites W2044534774 @default.
• W2117700031 cites W2046862553 @default.
• W2117700031 cites W2052745477 @default.
• W2117700031 cites W2065886456 @default.
• W2117700031 cites W2078797149 @default.
• W2117700031 cites W2083311645 @default.
• W2117700031 cites W2086002849 @default.
• W2117700031 cites W2096234619 @default.
• W2117700031 cites W2100832209 @default.
• W2117700031 cites W2107919289 @default.
• W2117700031 cites W2116364705 @default.
• W2117700031 cites W2124244781 @default.
• W2117700031 cites W2136062652 @default.
• W2117700031 cites W2142885312 @default.
• W2117700031 cites W2150689181 @default.
• W2117700031 cites W2409069058 @default.
• W2117700031 cites W2802290858 @default.
• W2117700031 cites W4229877359 @default.
• W2117700031 cites W4292540530 @default.
• W2117700031 doi "https://doi.org/10.1111/j.1365-2249.2009.03971.x" @default.
• W2117700031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2745029" @default.
• W2117700031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19664143" @default.
• W2117700031 hasPublicationYear "2009" @default.
• W2117700031 type Work @default.
• W2117700031 sameAs 2117700031 @default.
• W2117700031 citedByCount "17" @default.
• W2117700031 countsByYear W21177000312012 @default.
• W2117700031 countsByYear W21177000312014 @default.
• W2117700031 countsByYear W21177000312015 @default.
• W2117700031 countsByYear W21177000312017 @default.
• W2117700031 countsByYear W21177000312018 @default.
• W2117700031 countsByYear W21177000312019 @default.
• W2117700031 countsByYear W21177000312020 @default.
• W2117700031 countsByYear W21177000312021 @default.
• W2117700031 countsByYear W21177000312022 @default.
• W2117700031 countsByYear W21177000312023 @default.
• W2117700031 crossrefType "journal-article" @default.
• W2117700031 hasAuthorship W2117700031A5019715351 @default.
• W2117700031 hasAuthorship W2117700031A5022147284 @default.
• W2117700031 hasAuthorship W2117700031A5029678899 @default.
• W2117700031 hasAuthorship W2117700031A5056019322 @default.
• W2117700031 hasAuthorship W2117700031A5056439899 @default.
• W2117700031 hasAuthorship W2117700031A5064226135 @default.
• W2117700031 hasAuthorship W2117700031A5080746000 @default.
• W2117700031 hasBestOaLocation W21177000312 @default.
• W2117700031 hasConcept C139563560 @default.
• W2117700031 hasConcept C154317977 @default.
• W2117700031 hasConcept C167672396 @default.
• W2117700031 hasConcept C202751555 @default.
• W2117700031 hasConcept C203014093 @default.
• W2117700031 hasConcept C2776090121 @default.
• W2117700031 hasConcept C2776914184 @default.
• W2117700031 hasConcept C55493867 @default.
• W2117700031 hasConcept C86803240 @default.
• W2117700031 hasConcept C8891405 @default.
• W2117700031 hasConceptScore W2117700031C139563560 @default.
• W2117700031 hasConceptScore W2117700031C154317977 @default.
• W2117700031 hasConceptScore W2117700031C167672396 @default.
• W2117700031 hasConceptScore W2117700031C202751555 @default.
• W2117700031 hasConceptScore W2117700031C203014093 @default.
• W2117700031 hasConceptScore W2117700031C2776090121 @default.
• W2117700031 hasConceptScore W2117700031C2776914184 @default.
• W2117700031 hasConceptScore W2117700031C55493867 @default.
• W2117700031 hasConceptScore W2117700031C86803240 @default.
• W2117700031 hasConceptScore W2117700031C8891405 @default.
• W2117700031 hasIssue "3" @default.
• W2117700031 hasLocation W21177000311 @default.
• W2117700031 hasLocation W21177000312 @default.
• W2117700031 hasLocation W21177000313 @default.

• next